WNT3A and diabetes mellitus: All these findings reveal that ASCs-exos have great potential in advancing the osteogenic differentiation of BMSCs via activating the Wnt3a/β-catenin signaling pathway, and provide a novel direction for the treatment of fracture nonunion in DM.